Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sakae Tanaka

Showing results (11-20 of 913) with videos related to

Pageof 92
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 16, 2006
[Bone disease related to rheumatoid arthritis]Sakae Tanaka
EFORT Open Reviews|May 7, 2019
Molecular understanding of pharmacological treatment of osteoporosisSakae Tanaka
Clinical Calcium|April 4, 2007
[RANKL as a target molecule for treatment of joint destruction]Sakae Tanaka
American Journal of Nephrology|July 27, 2007
Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG systemSakae Tanaka
Clinical Calcium|September 5, 2006
[Current topics in drug therapy aiming at bone resorption]Tetsuro Yasui, Sakae Tanaka
Clinical Calcium|March 26, 2016
[Transcriptome analysis and epigenetic analysis during osteoclastogenesis]Shinya Nakamura, Sakae Tanaka
Current Opinion in Cell Biology|February 10, 2022
Plasmalemmal interface for calcium signaling in osteoclast differentiationHiroyuki Okada, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 13, 2009
[Drugs under development for osteoporosis ]Hironari Masuda, Sakae Tanaka
Clinical Calcium|March 3, 2009
[Prevention of joint destruction by osteoclast-targeting therapy in search of new tools, such as OPG or cathepsin K inhibitor]Yuho Kadono, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 17, 2005
[RANKL vaccination]Takuo Juji, Sakae Tanaka
Pageof 92

Showing results (11-20 of 913) with videos related to

Sort By:
Pageof 92
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 16, 2006
[Bone disease related to rheumatoid arthritis]Sakae Tanaka
EFORT Open Reviews|May 7, 2019
Molecular understanding of pharmacological treatment of osteoporosisSakae Tanaka
Clinical Calcium|April 4, 2007
[RANKL as a target molecule for treatment of joint destruction]Sakae Tanaka
American Journal of Nephrology|July 27, 2007
Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG systemSakae Tanaka
Clinical Calcium|September 5, 2006
[Current topics in drug therapy aiming at bone resorption]Tetsuro Yasui, Sakae Tanaka
Clinical Calcium|March 26, 2016
[Transcriptome analysis and epigenetic analysis during osteoclastogenesis]Shinya Nakamura, Sakae Tanaka
Current Opinion in Cell Biology|February 10, 2022
Plasmalemmal interface for calcium signaling in osteoclast differentiationHiroyuki Okada, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 13, 2009
[Drugs under development for osteoporosis ]Hironari Masuda, Sakae Tanaka
Clinical Calcium|March 3, 2009
[Prevention of joint destruction by osteoclast-targeting therapy in search of new tools, such as OPG or cathepsin K inhibitor]Yuho Kadono, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 17, 2005
[RANKL vaccination]Takuo Juji, Sakae Tanaka
Pageof 92